| Date Filed | Type | Description |
| 06/13/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 06/13/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/13/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 06/13/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 06/13/2023 |
8-K
| Filed for Chapter 11 |
| 05/25/2023 |
8-K
| Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/26/2023 |
8-K
| Quarterly results |
| 03/24/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/15/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits Interactive Data |
| 03/03/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G/A
| Frazier Life Sciences Public Fund, L.P. reports a 2.5% stake in Tricida, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 0.9% stake in TRICIDA, INC. |
| 01/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/17/2023 |
8-K
| Quarterly results |
| 01/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direc... |
| 01/04/2023 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 12/22/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/12/2022 |
8-K
| Quarterly results |
| 12/07/2022 |
8-K
| Quarterly results |
| 11/25/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/02/2022 |
8-K
| Quarterly results |
| 10/28/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.4% stake in Tricida, Inc. |
| 10/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/24/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
8-K
| Quarterly results |
| 10/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/28/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 16% stake in Tricida, Inc. |
|